Related content

Radiation Therapy and Concurrent Cisplatin in Management of Locoregionally Advanced Nasopharyngeal Carcinomas

By Serin Meltem   Erkal Haldun Ş.   Çakmak Ahmet  

Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. : 1031-1035

Informa Healthcare

Access to resources Recommend Favorite

Phase II trial of concurrent chemoradiotherapy with S1 versus weekly cisplatin for locoregionally advanced nasopharyngeal carcinoma

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 687-691

Science Publishers

Access to resources Recommend Favorite

Weekly Chemotherapy with Cisplatin and Paclitaxel and Concurrent Radiation Therapy as Preoperative Treatment in Locally Advanced Esophageal Cancer: A Phase II Study

By Orditura Michele   Galizia Gennaro   Napolitano Vincenzo   Martinelli Erika   Pacelli Roberto   Lieto Eva   Aurilio Gaetano   Vecchione Loredana   Morgillo Floriana   Catalano Giuseppe   Ciardiello Fortunato   Genio Alberto Del   Martino Natale Di   De Vita Ferdinando  

Cancer Investigation, Vol. 28, Iss. 8, 2010-09 ,pp. : 820-827

Informa Healthcare

Access to resources Recommend Favorite

Competing causes of death in patients with locoregionally advanced head and neck cancer treated with concomitant boost radiation plus concurrent weekly cisplatin

By Gómez-Millán Jaime  

Clinical and Translational Oncology, Vol. 15, Iss. 4, 2013-04 ,pp. : 321-326

Springer Publishing Company

Access to resources Recommend Favorite

Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer

By Solomon B.   Ball D.L.   Richardson G.   Smith J.G.   Millward M.   MacManus M.   Michael M.   Wirth A.   O'Kane C.   Muceniekas L.   Ryan G.   Rischin D.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 353-361

Elsevier

Access to resources Recommend Favorite